<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01368575</url>
  </required_header>
  <id_info>
    <org_study_id>TIME-002</org_study_id>
    <nct_id>NCT01368575</nct_id>
  </id_info>
  <brief_title>Surgical Treatment of Ischemic Mitral Regurgitation</brief_title>
  <acronym>TIME</acronym>
  <official_title>The Effect of Different Surgical Methods in the Treatment of Patients With Ischemic Mitral Regurgitation and Assess the Dynamics of Heart Failure and the Effectiveness of Surgical Treatment of Mitral Valve.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Meshalkin Research Institute of Pathology of Circulation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Meshalkin Research Institute of Pathology of Circulation</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective is to estimate surgical treatment (prosthesis or plastic) of moderate
      and severe ischemic mitral regurgitation combined with CABG in patients with CAD and impact
      on heart failure and progress of mitral regurgitation.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>May 2011</start_date>
  <completion_date type="Anticipated">November 2015</completion_date>
  <primary_completion_date type="Actual">May 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Assess the degree of mitral regurgitation in the early and late term of the study. Identify the cause of the return of IMR. Determine the dynamics of heart failure in patients with IMR.</measure>
    <time_frame>3,6,12,24,36 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assessment of IMR</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Anticipated">420</enrollment>
  <condition>Mitral Valve Insufficiency</condition>
  <arm_group>
    <arm_group_label>subgroup B1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>subgroup B1 will receive CABG combined with MV repair with annuloplasty rigid ring</description>
  </arm_group>
  <arm_group>
    <arm_group_label>subgroup B2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>B2 - CABG combined with MV repair with remodeling annuloplasty rigid ring and endoventricularplasty of subvalvular apparatus</description>
  </arm_group>
  <arm_group>
    <arm_group_label>subgroup A2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>CABG combined with MV repair with remodeling annuloplasty rigid ring</description>
  </arm_group>
  <arm_group>
    <arm_group_label>subgroup A1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>only CABG</description>
  </arm_group>
  <arm_group>
    <arm_group_label>subgroup B3</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patients in subgroup B3 will be performed CABG and MV replacement with preservation of subvalvular apparatus</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>CABG</intervention_name>
    <description>CABG</description>
    <arm_group_label>subgroup A1</arm_group_label>
    <other_name>will be performed only CABG (subgroup A1)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>CABG combined with MV repair with remodeling annuloplasty rigid ring</intervention_name>
    <description>CABG combined with MV repair with remodeling annuloplasty rigid ring</description>
    <arm_group_label>subgroup A2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>CABG combined with MV repair with remodeling annuloplasty rigid ring</intervention_name>
    <description>CABG combined with MV repair with remodeling annuloplasty rigid ring</description>
    <arm_group_label>subgroup B1</arm_group_label>
    <other_name>patients in subgroup B1 will receive CABG combined with MV repair with remodeling annuloplasty rigid ring</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>CABG combined with MV repair with remodeling annuloplasty rigid ring and endoventricularplasty of subvalvular apparatus</intervention_name>
    <description>CABG combined with MV repair with remodeling annuloplasty</description>
    <arm_group_label>subgroup B2</arm_group_label>
    <other_name>CABG grafting combined with MV repair with remodeling annuloplasty and endoventricularplasty of subvalvular</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>CABG and MV replacement</intervention_name>
    <description>coronary artery bypass grafting and mitral valve replacement</description>
    <arm_group_label>subgroup B3</arm_group_label>
    <other_name>patients in subgroup B3 will be performed CABG and MV replacement with preservation of subvalvular apparatus</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient is a male or female between 30 to 75 years of age (inclusive) on the day of
             signing the informed consent.

          -  Patients with a verified diagnosis of CAD, including post myocardial infarction scar.

          -  Coronary artery pathology to be coronary artery bypasses grafting.

          -  The presence of moderate or severe ischemic mitral regurgitation.

        Exclusion Criteria:

          -  The patient did not sign the informed consent.

          -  Aortic valve disease requiring prosthetic or aortic valve repair.

          -  Organic lesion of valve and subvalvular structures (endocarditis and degenerative
             processes of the mitral valve).

             а) separation of the mitral valve chords; б) rupture and perforation of the mitral
             valve; в) myxomatous degeneration and calcification of the mitral valve

          -  Patients with acute coronary syndrome.

          -  The presence of the indications for angioplasty of the coronary arteries.

          -  Coronary artery bypasses grafting in history.

          -  Parallel patient participation in other studies.

          -  The organs diseases, which can be reason to death after surgery during the first 3
             years.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alexander Cherniavskiy, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>State Research Institute of Circulation Patholody Novosibirsk, 630055 Russian Federation</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alexander Cherniavskiy, MD, Prof.</last_name>
    <phone>+7 383 3322655</phone>
    <email>amchern@mail.ru</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Vidadi Efendiev, MD</last_name>
    <phone>+7 383 3322655</phone>
    <email>vidadiue@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>State Research Institute of Circulation Patholody</name>
      <address>
        <city>Novosibirsk</city>
        <zip>630055</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexander Cherniavskiy, MD, PhD</last_name>
      <phone>+73833322655</phone>
      <email>amchern@mail.ru</email>
    </contact>
    <contact_backup>
      <last_name>Vidadi Efendiev, M.D</last_name>
      <phone>+73833322655</phone>
      <email>vidadiue@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Vidadi Efendiev, MD.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Russian Federation</country>
  </location_countries>
  <verification_date>September 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 24, 2011</study_first_submitted>
  <study_first_submitted_qc>June 7, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 8, 2011</study_first_posted>
  <last_update_submitted>September 21, 2015</last_update_submitted>
  <last_update_submitted_qc>September 21, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 23, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Ischemic</keyword>
  <keyword>Mitral</keyword>
  <keyword>Valve</keyword>
  <keyword>Insufficiency</keyword>
  <keyword>SVR</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mitral Valve Insufficiency</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

